Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

C. L. White, K. R. Twigger, L. Vidal, J. S. De Bono, M. Coffey, L. Heinemann, R. Morgan, A. Merrick, F. Errington, R. G. Vile, A. A. Melcher, H. S. Pandha, K. J. Harrington

Research output: Contribution to journal › Article › peer-review

103 Scopus citations

Fingerprint

Dive into the research topics of 'Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences